Review: taking Buspar and Cyclobenzaprine hydrochloride together


Summary

Drug interactions are reported among people who take Buspar and Cyclobenzaprine hydrochloride together. This review analyzes the effectiveness and drug interactions between Buspar and Cyclobenzaprine hydrochloride. It is created by eHealthMe based on reports of 619 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Buspar and Cyclobenzaprine hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Buspar

Buspar has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. (latest outcomes from Buspar 11,860 users)

Cyclobenzaprine Hydrochloride

Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. (latest outcomes from Cyclobenzaprine hydrochloride 2,728 users)

On Aug, 29, 2016

619 people who take Buspar, Cyclobenzaprine Hydrochloride are studied.


Number of reports submitted per year:

Buspar and Cyclobenzaprine hydrochloride drug interactions.

Drug effectiveness over time:

Buspar:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 9 people)
  • 6 - 12 months: 0.0% - (0 of 7 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 50.0% - (3 of 6 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Cyclobenzaprine Hydrochloride:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 25.0% - (2 of 8 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 3 people)
  • 2 - 5 years: 16.0% - (1 of 6 people)
  • 5 - 10 years: 80.0% - (4 of 5 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Buspar:
  • female: 25.0% - (7 of 27 people)
  • male: 0.0% - (0 of 4 people)
Cyclobenzaprine Hydrochloride:
  • female: 26.0% - (7 of 26 people)
  • male: 25.0% - (1 of 4 people)

Drug effectiveness by age:

Buspar:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 16.0% - (1 of 6 people)
  • 30-39: 10.0% - (1 of 10 people)
  • 40-49: 55.0% - (5 of 9 people)
  • 50-59: 0.0% - (0 of 5 people)
  • 60+: 0.0% - (0 of 1 people)
Cyclobenzaprine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 25.0% - (1 of 4 people)
  • 30-39: 27.0% - (3 of 11 people)
  • 40-49: 33.0% - (3 of 9 people)
  • 50-59: 20.0% - (1 of 5 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • panic attack
  • abnormal dreams
  • blood glucose increased
  • blood magnesium increased
  • blood sodium increased
  • body temperature decreased
  • brain death
  • cardiac failure
  • cardio-respiratory arrest
  • coma
1 - 6 months:
  • lightheadedness - fainting
  • nervousness
  • shortness of breath
  • swelling of the ankles - feet - legs
  • anxiety and stress
  • bipolar 1
  • heart disease - aging
  • hypertension
  • hypothyroidism
  • migraine
6 - 12 months:
  • panic attack
  • pulse
  • acid reflux
  • anxiety disorder
  • chronic depression
  • dizziness
  • high blood cholesterol
  • high blood pressure
  • muscle pain
  • restless leg syndrome
1 - 2 years:
  • dry mouth
  • dry skin
  • swelling in the abdomen
  • swelling of the ankles - feet - legs
  • weight gain
  • biliary dyskinesia
  • deep vein thrombosis
  • injury
  • mental disorder
  • pain
2 - 5 years:
  • lightheadedness - fainting
  • nervousness
  • shortness of breath
  • swelling of the ankles - feet - legs
  • cholecystitis chronic
  • gallbladder disorder
  • pain
  • pancreatitis
  • sphincter of oddi dysfunction
  • anxiety
5 - 10 years:
  • cyanosis
  • emotional distress
  • peripheral ischaemia
  • arterial thrombosis
  • cholecystitis chronic
  • drug hypersensitivity
  • gallbladder disorder
  • pancreatitis
  • pain
  • anxiety
10+ years:
  • anxiety and stress
  • bipolar 1
  • heart disease - aging
  • hypertension
  • hypothyroidism
  • migraine
  • muscle contracture
  • pain exacerbated
not specified:
  • depression
  • pain
  • anxiety
  • chest pain
  • headache
  • nausea
  • weight increased
  • arthralgia
  • back pain
  • type 2 diabetes mellitus

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • depression
  • chest pain
  • arthralgia
  • headache
  • pain in extremity
  • abdominal pain
  • drug ineffective
  • type 2 diabetes mellitus
male:
  • depression
  • suicidal ideation
  • pain
  • anxiety
  • bipolar i disorder
  • emotional distress
  • rash
  • agitation
  • memory impairment
  • injury

Most common drug interactions by age *:

10-19:
  • cholecystitis chronic
  • gallbladder disorder
  • pain
  • pancreatitis
  • sphincter of oddi dysfunction
  • deep vein thrombosis
  • menstruation irregular
  • pelvic pain
  • pharyngitis
  • pulmonary embolism
20-29:
  • pulmonary embolism
  • cholelithiasis
  • gallbladder disorder
  • muscle spasms
  • abdominal pain
  • dyspepsia
  • vomiting
  • anxiety
  • abdominal pain upper
  • abdominal tenderness
30-39:
  • serotonin syndrome
  • completed suicide
  • loss of consciousness
  • respiratory depression
  • overdose
  • anticholinergic syndrome
  • nausea
  • neck pain
  • alcohol withdrawal syndrome
  • chest pain
40-49:
  • anxiety
  • depression
  • pain
  • rash
  • type 2 diabetes mellitus
  • weight increased
  • emotional distress
  • suicidal ideation
  • drug ineffective
  • headache
50-59:
  • weight increased
  • pain
  • swelling of the ankles - feet - legs
  • pancreatitis
  • type 2 diabetes mellitus
  • arthralgia
  • depression
  • anxiety
  • diabetes mellitus
  • lightheadedness - fainting
60+:
  • dyspnoea
  • depression
  • anxiety
  • asthenia
  • pain
  • urinary tract infection
  • chest discomfort
  • fall
  • chest pain
  • neck pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Buspar and Cyclobenzaprine hydrochloride?

Can you answer these questions?

More questions for: Buspar, Cyclobenzaprine hydrochloride

You may be interested in these reviews

More reviews for: Buspar, Cyclobenzaprine hydrochloride

On eHealthMe, Buspar (buspirone hydrochloride) is often used to treat stress and anxiety. Cyclobenzaprine hydrochloride (cyclobenzaprine hydrochloride) is often used to treat muscle spasms. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.